TherapeuticsMD (TXMD) EBITDA (2010 - 2026)
TherapeuticsMD (TXMD) recorded EBITDA of -$721,000 in Q2 2026, compared with -$599,000 a year earlier.
Powered by 
Analysis
TherapeuticsMD (TXMD) EBITDA (2010 - 2026) Analysis & Trends
On a TTM basis, TherapeuticsMD's EBITDA came in at -$3.57 million as of Jun 30, 2026; for FY2025, it was -$4.01 million.
- Across earlier years, EBITDA came in at -$5.6 million in FY2024, -$7.6 million in FY2023, $2.38 million in FY2022 and -$78.84 million in FY2021.
- Quarterly EBITDA has ranged from -$38.89 million in Q3 2021 to $48.75 million in Q4 2022 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$629,000 (Q1 2026), -$1.46 million (Q4 2025) and -$766,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | -721,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -721,000.00 |
| Mar 31, 2026 | -629,000.00 |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | -766,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -552,000.00 |
| Sep 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -2.61 Mn |
| Mar 31, 2024 | -1.01 Mn |
| Dec 31, 2023 | -974,000.00 |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -2.34 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | 48.75 Mn |
| Sep 30, 2022 | -14.25 Mn |
| Jun 30, 2022 | -14.58 Mn |
| Mar 31, 2022 | -17.55 Mn |
| Dec 31, 2021 | -37.75 Mn |
| Sep 30, 2021 | -38.89 Mn |
API Access
TherapeuticsMD EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();